Selexipag
Back to searchMolecule Structure
Scientific Name
Selexipag
Description of the Drug
Selexipag is a non prostanoid IP prostacyclin receptor agonist used to treat pulmonary arterial hypertension.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11362
http://www.drugbank.ca/drugs/DB11362
Brand Name(s)
Uptravi
Company Owner(s)
Actelion Pharmaceuticals Us Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Prostanoid IP receptor | SINGLE PROTEIN | AGONIST | CHEMBL1995 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL674122 | |
| PharmGKB | PA166281602 | |
| Human Metabolome Database | HMDB0258215 | |
| DrugBank | DB11362 | |
| PubChem: Thomson Pharma | 14884195 | |
| PubChem | 9913767 | |
| Nikkaji | J2.120.977E | |
| BindingDB | 50235383 | |
| DrugCentral | 5077 | |
| ChemicalBook | CB63166208 | CB32454222 |
| Guide to Pharmacology | 7552 | |
| rxnorm | UPTRAVI | SELEXIPAG |
| ChEBI | 90844 | |
| ZINC | ZINC000003990451 |
